Acton Pharma Raises $15 Million
Acton Pharmaceuticals Inc., a Marlborough, Mass.-based respiratory pharma startup, has raised $15 million in Series A funding led by Sequoia Capital. The company also announced that it has licensed the Aerospan inhalation aerosol from Forest Labs (NYSE: FRX).
6 January 2010•5 mins read
